Shore Capital reaffirmed their house stock rating on shares of Synectics (LON:SNX - Free Report) in a report published on Tuesday, Marketbeat Ratings reports.
Synectics Stock Down 3.2 %
Shares of SNX traded down GBX 10 ($0.13) during midday trading on Tuesday, reaching GBX 305 ($3.83). 33,735 shares of the stock were exchanged, compared to its average volume of 48,509. The company has a current ratio of 2.02, a quick ratio of 1.42 and a debt-to-equity ratio of 4.04. The company's 50 day moving average is GBX 274.70 and its two-hundred day moving average is GBX 216.48. Synectics has a 52 week low of GBX 100.20 ($1.26) and a 52 week high of GBX 328 ($4.12). The company has a market capitalization of £54.26 million, a P/E ratio of 1,714.81 and a beta of 0.69.
About Synectics
(
Get Free Report)
Synectics plc engages in the design, integration, and support of security and surveillance systems in the United Kingdom and internationally. It operates through two segments: Systems and Security. The Systems segment provides specialist electronic surveillance systems comprising Synergy, a security and surveillance software platform; and radiometrics-enabled COEX explosion-proof cameras for gaming, transport, critical infrastructure, public space, and oil and gas applications.
See Also
Before you consider Synectics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synectics wasn't on the list.
While Synectics currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
